Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?
@article{ATM110810,
author = {Karen Van Baelen and Christine Desmedt and Hans Wildiers and Patrick Neven},
title = {Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?},
journal = {Annals of Translational Medicine},
volume = {11},
number = {6},
year = {2023},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/110810}
}